8 estimates ahead of Optomeds report
4 november, 09:31
4 november, 09:31
Ahead of Optomeds's Q3-report (to be published on 6 november), investors on Pinpoint Estimates expect revenues and earnings within the following weighted ranges:
Net sales: 3.66 - 4.07 MEUR
Previous outcome (2024-Q3): 3.1 MEUR
EBIT: (-1.21) - (-0.81) MEUR
Previous outcome (2024-Q3): (-1.4) MEUR
The data is based on 8 investors estimates. Visit pinpointestimates.com to access Pinpoint's consensus figure and other investors' estimates ahead of the report.
Pinpoint Estimates is a platform that compiles estimates from private investors and analysts before publicly traded companies' reports. The estimates are weighted based on each user's historical accuracy and compiled into a consensus.
Access Pinpoint's consensus for Optomeds quarterly and annual results at pinpointestimates.com.
4 november, 09:31
Ahead of Optomeds's Q3-report (to be published on 6 november), investors on Pinpoint Estimates expect revenues and earnings within the following weighted ranges:
Net sales: 3.66 - 4.07 MEUR
Previous outcome (2024-Q3): 3.1 MEUR
EBIT: (-1.21) - (-0.81) MEUR
Previous outcome (2024-Q3): (-1.4) MEUR
The data is based on 8 investors estimates. Visit pinpointestimates.com to access Pinpoint's consensus figure and other investors' estimates ahead of the report.
Pinpoint Estimates is a platform that compiles estimates from private investors and analysts before publicly traded companies' reports. The estimates are weighted based on each user's historical accuracy and compiled into a consensus.
Access Pinpoint's consensus for Optomeds quarterly and annual results at pinpointestimates.com.
Analyser
Börsen
Kinneviks VD slutar
USA
Analyser
Börsen
Kinneviks VD slutar
USA
OMX Stockholm 30
1 DAG %
Senast
2 704,05
